What Unifarco does

Unifarco S.p.A. is an Italian privately-held manufacturer and B2B supplier of cosmetic, nutraceutical, dermatological, medical-device, and functional-food products, founded in 1982 in Santa Giustina, Belluno, and operating as a cooperative-style enterprise owned by its pharmacist-members. The company serves more than 6,800 independent pharmacies across six European countries (Italy, Germany, Spain, France, Austria, and Switzerland) through wholly-owned subsidiaries, with 501-1,000 employees and production capacity exceeding 61,000 products packaged daily.

The technical core is a multi-brand, multi-category portfolio spanning seven sub-brands: Farmacisti Preparatori (private-label pharmacist formulations), Ceramol (dermo-cosmetics and medical devices), Biomalife (gut-health nutraceuticals), Dolomia (Dolomite phyto-cosmetics), MyCli (aesthetic-medicine supplements), Keylife (functional metabolic foods), and GenAge (genetic/epigenetic precision nutraceuticals). Underpinning this portfolio are 6 in-house laboratories staffed by 50+ degreed researchers, 24 patents filed since 2005, a proprietary formulation software that evaluates more than 10 parameters for environmental-impact optimization, and Life Cycle Assessment (LCA) methodology applied across the product lifecycle. R&D is supplemented by a scientific network of universities (including University of Padua spin-off Unired) and specialist institutes.

The business model is B2B2C: Unifarco manufactures and supplies formulations, finished private-label products, and contract-manufactured goods to pharmacies, which then sell under their own brands or under the company's branded lines. Revenue is generated through product sales (private label, branded, and contract manufacturing) plus ancillary educational and support services for pharmacists. Pricing is not publicly disclosed and is negotiated by volume and specification. The company is unlisted, holds no external parent or institutional investor, and is funded internally with one disclosed public R&D grant of EUR 39,247.08 in 2021.

Name

Unifarco

Legal name

Unifarco S.p.A.

Website

https://unifarco.it

Company type

Private

Founded year

1982

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Unifarco S.p.A. is an Italian private manufacturer of cosmetic, nutraceutical, dermatological, medical-device, and functional-food products, supplying over 6,800 independent pharmacies across six European countries through seven proprietary brands and contract manufacturing.

Ownership category

akta.pro rank

Headquarters

HQ city

Santa Giustina

HQ country

Italy

HQ region

Europe

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmacy Private Label / Store Brand Products: Unifarco enables independent pharmacies to offer proprietary health and beauty products under their own brand. This includes cosmetics, nutraceuticals, dermatological products, medical devices, and functional foods. The company handles formulation, production, and packaging while pharmacists sell under their own labels.
2. Branded Consumer Products: Sale of finished products under Unifarco's own brands including Ceramol (dermatological skincare), Biomalife (nutraceuticals for gut health), Dolomia (phyto-cosmetics from Dolomite extracts), MyCli (aesthetic medicine supplements), Keylife (functional foods), and GenAge (precision nutraceuticals).
3. Contract Manufacturing: Production services for pharmacy chains and other partners seeking custom formulations. Over 61,000 products packaged daily indicates significant manufacturing scale.
4. Educational and Support Services: Training programs for pharmacists, continuing education, and consulting services to support pharmacy professionals.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Unifarco is a B2B pharmaceutical and cosmetics manufacturer that develops, formulates, and produces private-label and branded health, beauty, and wellness products for distribution through independent pharmacies. The company operates six in-house laboratories staffed by more than 50 researchers, holds 24 patents, and runs an 61,000+ unit-per-day manufacturing operation covering cosmetics, nutraceuticals, dermatological products, medical devices, and functional foods across seven proprietary brands and pharmacy private-label lines.

Product overview

Unifarco operates as a B2B pharmaceutical and cosmetics manufacturer serving pharmacies across Europe. The company offers a multi-brand portfolio centered around seven distinct sub-brands: Farmacisti Preparatori (private-label pharmacy formulations), Ceramol (dermatological skincare), Biomalife (intestinal health nutraceuticals), Dolomia (phytocosmetic Dolomite-based products), MyCli (aesthetic anti-aging supplements), Keylife (functional metabolic foods), and GenAge (precision longevity nutraceuticals). Products span cosmetics, nutraceuticals, medical devices, dermo-cosmetics, make-up, and functional foods. The company serves over 6,800 pharmacies across 6 European countries, operates 6 laboratories with 50+ researchers, holds 24 patents, and produces over 61,000 products daily.

Differentiator

Problem solved

Functional benefit

Brands

• Farmacisti Preparatori (Pharmacists Preparators): A scientific community united by the same professional ethics and mission: to guarantee the health and beauty of people. Develops cosmetics, supplements, and solutions bearing the pharmacist's signature to offer concrete responses to every wellness need.
• Ceramol
• Biomalife
• Dolomia
• MyCli
• Keylife
• GenAge

Products and services

• Farmacisti Preparatori (Pharmacists Preparators) Private-label and pharmacist-signed line of cosmetics, food supplements, and wellness solutions developed for independent pharmacies to sell under their own brand. Targets independent pharmacies serving end consumers seeking trustworthy health and beauty advice.
• Ceramol Dermatological skincare brand of medical devices and dermo-cosmetics with high technological content and tolerability, developed for skin-barrier problems. Sold through independent pharmacies for consumers with sensitive or pathological skin.
• Biomalife Nutraceutical line focused on gastrointestinal-tract and intestinal-barrier wellness, developed with specialist doctors and biochemists. Distributed through pharmacies for consumers seeking advanced gut-health supplementation.
• Dolomia Phytocosmetic skincare and make-up brand leveraging botanical extracts from the Dolomites to counter stress, pollution, and skin aging. EPD-certified products are marketed as carbon neutral. Sold through independent pharmacies.
• MyCli Aesthetic-medicine brand combining anti-aging cosmetic technologies with nutritional supplements in a single integrated line, developed for aesthetic-medicine professionals and their patients. Sold through pharmacies.
• Keylife Functional-food brand integrating medicine, clinical nutrition, and food technology to act on metabolic markers such as glycemia, low-grade inflammation, and anti-aging. Distributed through pharmacies as food-based metabolic support.
• GenAge Personalized precision nutraceutical line based on genetic and epigenetic analysis to customize anti-aging interventions, developed with geroscience specialists and Metodo Ongaro SA. Distributed through pharmacies serving longevity-focused consumers.
• Contract Manufacturing Services Custom formulation development and high-volume production/packaging services offered to pharmacy chains and partner organizations seeking proprietary health and beauty formulations under their own specifications.
• Pharmacist Education and Training Programs Continuing-education programs, professional training, and consulting support delivered to independent pharmacy partners to support product expertise, regulatory knowledge, and customer advisory capability.

Quantifiable outcome

• Over 6,800 pharmacy clients served across 6 European countries
• +3 more outcomes

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• Unired (Spin-off of University of Padua)coreStrategic or Co-development PartnerUnifarco's Nutraceutical Research and Development Laboratory collaborated with Unired, a spin-off from the University of Padua, for characterizing functional ingredient mixtures using rheology and other dedicated methods to study technological properties of each mixture for nutraceutical product development.
• Croce Rossa Italiana (Italian Red Cross)coreGTM or Marketing PartnerUnifarco supports the Italian Red Cross annually through its pharmacy network, providing assistance to those most in need of healthcare services. This partnership demonstrates the company's commitment to social responsibility.
• Rete ClimaminorStrategic or Co-development PartnerUnifarco partnered with Rete Clima to develop a carbon offsetting plan for their products. Through the purchase of 1,000 carbon credits, they finance international reforestation projects in the Amazon rainforest (Brazil) and a hydroelectric plant in India.
• Rotary ClubminorStrategic or Co-development PartnerCollaboration with Rotary Club for the Ikonda Pharmacy project in southern Tanzania, which involved renovating a pharmacy adjacent to a district hospital.
• Amici di Ikonda HospitalminorStrategic or Co-development PartnerPartnership with the Italian organization managing the Ikonda Hospital district pharmacy project in Tanzania.
• Metodo Ongaro SAcoreStrategic or Co-development PartnerCollaboration with Metodo Ongaro SA, doctors, geneticists, and international researchers for the development of GenAge precision nutraceuticals.
• La Forza e il Sorriso ONLUSminorGTM or Marketing PartnerUnifarco contributes products, advice, and resources to support this nonprofit organization that provides moral and psychological support to women undergoing cancer treatment through beauty workshops.
• Various Universities and Research InstitutescoreStrategic or Co-development PartnerUnifarco maintains an important scientific network at national and international levels, constantly engaging with doctors and specialists, and maintaining daily dialogue with prestigious universities and research centers.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• La Roche-Posay (L'Oréal): L'Oréal-owned pharmacy-distributed dermo-cosmetic brand, the dominant force in the same pharmacy skincare category where Unifarco's Ceramol competes — comparable distribution and positioning but as part of a large incumbent global beauty company's portfolio.
• Almirall: Spanish dermatology-focused pharmaceutical company with broader Rx portfolio plus OTC dermo-cosmetics; comparable dermatology focus and European pharmacy distribution but a much larger R&D-led prescription drug business.
• Eucerin (Beiersdorf): Beiersdorf-owned dermo-cosmetic brand distributed primarily through European pharmacies with scientifically positioned formulations — directly comparable category and channel but as part of a global FMCG parent.

Direct peers

• Pierre Fabre: French dermo-cosmetic and pharmaceutical company manufacturing skincare and health products sold primarily through European pharmacies via brands like Avène and Ducray — the closest analog to Unifarco's private-label + branded model serving pharmacy partners.
• ISDIN: Spanish dermocosmetics company founded in 1975 that builds dermo-cosmetic, photoprotection, and gynecological product brands distributed through European pharmacies — highly comparable business model and European geographic footprint.
• Perrigo Company: US/Irish headquartered OTC and consumer self-care products manufacturer with extensive European private-label and store-brand pharmacy business — closest large-scale analog of Unifarco's pharmacy private-label manufacturing model.
• Galderma: Swiss-headquartered dermatology-focused pharma company (formerly Nestlé/L'Oréal joint venture, now privately owned) marketing prescription and dermo-cosmetic products through dermatologists and pharmacies — directly comparable in dermo-cosmetic positioning.
• Cantabria Labs: Spanish dermocosmetics manufacturer behind Heliocare, Endocare, and Biretix sold through pharmacy channels across Europe and Latin America — comparable in scale, channel, and category breadth to Unifarco's Ceramol/Biomalife brands.
• Laboratoires Pierre Fabre dermo-cosmétique competitors — Uriage (Puig): French thermal-water dermo-cosmetic brand owned by Puig, sold predominantly through European pharmacies — directly comparable in pharmacy-exclusive dermo-cosmetic positioning to Unifarco's Ceramol and Dolomia brands.
• NAOS Group (Bioderma): French independent manufacturer behind Bioderma pharmacy skincare and Institut Esthederm, with the same B2B pharmacy channel model and multi-brand portfolio structure as Unifarco, including private-label capabilities.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/unifarco-spa

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Unifarco